Patients' preferences for systemic treatment of atopic dermatitis: safety and efficacy count the most
AbstractBackground The advent of biologics and janus kinase inhibitors has revolutionized treatment of atopic dermatitis (AD).Objective To investigate preferences of patients with AD for attributes of currently approved systemic treatments and assess influencing factors.Methods An online discrete ch...
Bewaard in:
Hoofdauteurs: | , , , , |
---|---|
Formaat: | Boek |
Gepubliceerd in: |
Taylor & Francis Group,
2024-12-01T00:00:00Z.
|
Onderwerpen: | |
Online toegang: | Connect to this object online. |
Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|
Wees de eerste die reageert!